Latest News & Features
Europe
Haseltine Lake Kempner has added Jo Deas as a partner to its chemistry and life sciences team, effective January 20. 16 January 2020
Europe
In a dramatic reversal, a European Patent Office’s board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent. 16 January 2020
Big Pharma
A former Genentech employee has pleaded guilty to a reduced charge after offering "superseding information" to the FBI as part of an ongoing trade secrets investigation. 16 January 2020
Americas
Gilead and its alleged co-conspirators Bristol-Myers Squibb, Japan Tobacco, and Johnson & Johnson have been accused of engaging in a long-running scheme to suppress competition in the market for HIV prevention therapies. 16 January 2020
Europe
The European Patent Office intends to refer questions in the Broad Institute’s ongoing CRISPR patent case to the enlarged board of appeal, meaning the case is set to drag out further. 15 January 2020
Europe
The first day of a landmark hearing on CRISPR ownership dealt nearly exclusively with untangling linguistic arguments, lawyers following the proceedings told LSIPR. 14 January 2020
Biotechnology
German biotech Jennewein has accused Nestlé Nutrition of infringing patents covering a process of purifying human milk oligosaccharides to make its infant formula. 14 January 2020
Americas
California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs. 13 January 2020
Americas
A judge has refused to temporarily block California’s ban on pay-for-delay deals while a group of generics manufacturers appeal against the judge’s earlier decision. 13 January 2020
Big Pharma
Germany-based Bayer is collaborating with Exscientia, an artificial intelligence (AI)-driven drug discovery company, to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology. 10 January 2020